ScholarGate
Asistent

Porovnat metody

Prohlédněte si vybrané metody vedle sebe; řádky, které se liší, jsou zvýrazněny.

MDS-UPDRS×EDSS: Kurtzkeho rozšířená škála stavu postižení×RMI: Rivermead Mobility Index×
OborNeurologieNeurologieNeurologie
RodinaProcess / pipelineProcess / pipelineProcess / pipeline
Rok vzniku200819831991
TvůrceChristopher G. Goetz and Movement Disorder SocietyJohn F. KurtzkeFrank Collen, Derick Wade, and Rivermead Rehabilitation Centre
TypClinician-ratedClinician-ratedClinician-observed performance test
Původní zdrojGoetz, C. G., et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129-2170. DOI ↗Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444-1452. DOI ↗Collen, F. M., Wade, D. T., Robb, G. F., Bradshaw, C. M. (1991). The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment. International Disability Studies, 13(2), 50-54. DOI ↗
Další názvyUPDRSExpanded Disability Status ScaleRivermead Mobility Index
Příbuzné545
ShrnutíThe MDS-UPDRS is the gold-standard clinician-administered rating scale for assessing motor and non-motor manifestations of Parkinson's disease. Developed by the Movement Disorder Society in 2008 to enhance the original UPDRS, it measures disease severity across daily living, motor function, and treatment complications. Used globally in clinical trials, longitudinal cohort studies, and routine neurological practice.The EDSS is the most widely used clinical disability rating scale in multiple sclerosis research and practice. Developed by John Kurtzke in 1983, it provides a 0-10 ordinal scale capturing disease severity across eight neurological functional systems and functional status. The EDSS remains the primary endpoint in MS clinical trials and longitudinal cohort studies, with decades of prognostic and comparative data worldwide.The Rivermead Mobility Index (RMI) is a brief, clinician-observed performance test of basic mobility abilities developed for assessing stroke and neurological rehabilitation outcomes. Published in 1991 by Frank Collen and colleagues at Rivermead Rehabilitation Centre (Oxford, UK), the 15-item index measures bed mobility, sitting/standing balance, transfers, and ambulation. The RMI is widely used in stroke units and rehabilitation settings to track functional recovery and predict discharge outcomes.
ScholarGateDatová sada
  1. v1
  2. 1 Zdroje
  3. PUBLISHED
  1. v1
  2. 1 Zdroje
  3. PUBLISHED
  1. v1
  2. 1 Zdroje
  3. PUBLISHED

Přejít na hledání Stáhnout prezentaci

ScholarGatePorovnat metody: MDS-UPDRS · EDSS · RMI. Získáno 2026-06-19 z https://scholargate.app/cs/compare